In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
about
In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
In vivo and in vitro attenuati ...... ective KATP channel modulator.
@en
In vivo and in vitro attenuati ...... ective KATP channel modulator.
@nl
type
label
In vivo and in vitro attenuati ...... ective KATP channel modulator.
@en
In vivo and in vitro attenuati ...... ective KATP channel modulator.
@nl
prefLabel
In vivo and in vitro attenuati ...... ective KATP channel modulator.
@en
In vivo and in vitro attenuati ...... ective KATP channel modulator.
@nl
P2093
P2860
P1433
P1476
In vivo and in vitro attenuati ...... ective KATP channel modulator.
@en
P2093
B M Sharma
Prabhat Singh
Surbhi Gupta
P2860
P2888
P304
P356
10.1007/S00213-014-3680-5
P577
2014-07-26T00:00:00Z